Dietary supplement including He Shou Wu, parasitic loranthus and green tea to promote weight loss
A novel dietary supplement composition that serves to inhibit FAS for the purpose of controlling body weight and body fat levels. Administration of the composition, particularly to individuals with impaired glucose tolerance, may have the effect of restoring optimal glucose functioning, therefore lessening the likelihood of adipose storage and leading to a reduction in body fat and weight. The supplement may comprise He Shou Wu, parasitic loranthus and green tea. A composition of the dietary supplement, in orally taken capsule form, may include: (a) about 500 mg of an 1:1:1 ratio extract of He Shou Wu, parasitic loranthus and green tea; (b) about 200 mg Caffeine Anhydrous; (c) about 250 mg Cinnulin PF; (d) about 100 mg Evodia Rutaecarpa; (e) about 500 mg tyrosine; and (f) about 100 mg 7-keto DHEA. The supplement may also be administered as a tablet, powdered beverage, bar, gel or drink.
1. A dietary supplement comprising: He Shou Wu, parasitic loranthus and green tea wherein the He Shou Wu, parasitic loranthus and green tea are present in a ratio of 1:1:1 by weight.
2. The dietary supplement of claim 1 , further comprising an additive selected front a group consisting of: Epigallocatechin gallate, Tetradecyl Thioacetic Acid, Tyosine, Guggulsterones, Caffeine Anhydrous, Synephrine HCL, Yohimbine HCL, Evodia Rutaecarpa, Raspberry Ketone, Coleus Forshkohlii, Cinnulin PF, and 7-keto dehydroepiandrosterone (DHEA).
3. A dietary supplement comprising the following components:
a. about 1 to 10,000 mg of He Shou Wu extract;
b. about 1 to 10,000 mg green tea extract; and
c. about 1 to 10,000 mg parasitic loranthus extract wherein the He Shou Wu extract, parasitic loranthus extract and green tea extract are present at a ratio of 1:1:1 by weight.
4. The dietary supplement of claim 3 , further comprising an additive selected from a group consisting of: Epigallocatechin gallate, Tetradecyl Thioacetic Acid, Tyrosine, Guggulsterones, Caffeine Anhydrous, Synephrine HCL, Yohimbine HCL, Evodia Rutaecarpa, Raspberry Ketone, Coleus Forshkohlii, Cinnulin PF, and 7-keto DHEA.
5. The dietary supplement of claim 3 further comprising about 1 mg to 500 mg of Epigallocatechin gallate.
6. The dietary supplement of claim 3 further comprising about 1 mg to 100 mg of Guggulsterones.
7. The dietary supplement of claim 3 further comprising about 1 mg to 1000 mg of Tyrosine.
8. The dietary supplement of claim 3 further comprising about 1 mg to 2000 mg of Tetradecyl Thioacetic Acid.
9. The dietary supplement of claim 3 further comprising about 1 mg to 500 mg of Caffeine Anhydrous.
10. The dietary supplement of claim 3 further comprising about 1 mg to 100 mg of Synephrine HCL.
11. The dietary supplement of claim 3 further comprising about 1 mg to 100 mg of Yohimbine HCL.
12. The dietary supplement of claim 3 further comprising about 1 mg to 100 mg of Yohimbine HCL.
13. The dietary supplement of claim 3 further comprising about 1 mg to 500 mg of Evodia Rutaecarpa.
14. The dietary supplement of claim 3 further comprising about 1 mg to 500 mg of Raspberry Ketone.
15. The dietary supplement of claim 3 further comprising about 1 mg to 500 mg of Coleus Forshkohlii.
16. The dietary supplement of claim 3 further comprising about 1 mg to 500 mg of Cinnulin PF.
17. The dietary supplement of claim 3 further comprising about 1 mg to 500 mg of 7-keto DHEA.
18. A method for manufacturing a dietary supplement comprising the steps of:
providing a predetermined amount of He Shou Wu, parasitic loranthus and green tea;
mixing in a 1:1:1 ratio by weight the He Shou Wu, parasitic loranthus and green tea to form a composition;
processing the composition with a 50% ethanol solution to obtain a composition extract;
filtering the composition extract;
chilling the filtered extract;
processing the filtered extract to recover any remaining solvent; and
drying the processed filtered extract to yield a powder.
19. The method of claim 18 , further the step of packing the powder into an orally ingestible form.
20. The method of claim 19 , further the step of packing the orally ingestible form with an additive selected from a group consisting of: Epigallocatechin gallate, Tetradecyl Thioacetic Acid, Tyrosine, Guggulsterones, Caffeine Anhydrous, Synephrine HCL, Yohimbine HCL, Evodia Rutaecarpa, Raspberry Ketone, Coleus Forshkohlii, Cinnulin PF, and 7-keto DHEA.